+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Enzyme Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Enzyme Inhibitors - Global Strategic Business Report

  • Report
  • July 2025
  • 376 Pages
  • Global
From
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 192 Pages
  • Global
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 181 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 196 Pages
  • Global
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • July 2025
  • 293 Pages
  • Global
From
From
Antibody Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Antibody Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 577 Pages
  • Global
From
From
Non-cancerous Skin Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 222 Pages
  • Global
From
From
From
From
From
Loading Indicator